Clinical trial
Genetic Determinants of Warfarin Anticoagulation Effect
NCT00162435 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00162435 |
|---|---|
| Title | Genetic Determinants of Warfarin Anticoagulation Effect |
| Official title | Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | United States - Israel Binational Science Foundation Israel Science Foundation Ministry of Health, Israel |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Warfarin |
| Enrollment | 500 |
| Start date | Aug 1, 2002 |
| Primary completion | Dec 1, 2020 |
| Completion | Dec 1, 2020 |
| First posted | Sep 13, 2005 |
| Last update posted | Jun 12, 2018 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: